You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 14, 2025

Profile for Peru Patent: 20050696


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Peru Patent: 20050696

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free May 24, 2027 Msd Sub Merck JANUMET XR metformin hydrochloride; sitagliptin phosphate
⤷  Get Started Free May 24, 2027 Msd Sub Merck JANUMET metformin hydrochloride; sitagliptin phosphate
⤷  Get Started Free May 24, 2027 Merck Sharp Dohme JANUVIA sitagliptin phosphate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape for Peru Patent PE20050696

Last updated: July 27, 2025

Introduction

Peru Patent PE20050696 is a critical intellectual property asset within the pharmaceutical landscape, securing proprietary rights for a specific drug or formulation. This report provides a detailed analysis of the scope, claims, and the broader patent landscape surrounding PE20050696 to inform strategic decision-making for stakeholders involved in licensing, litigation, or R&D investments.

Patent Overview

  • Patent Number: PE20050696
  • Filing Date: Likely filed in 2005, given the designation, with examination potentially completed around 2006
  • Jurisdiction: Republic of Peru
  • Type: Likely a utility patent, covering a pharmaceutical compound, formulation, or method of use

Legal Status and Duration

As per Peruvian patent regulations, patents typically have a 20-year term from the filing date, subject to maintenance fees. Assuming PE20050696 was granted and maintained, its current status is active, providing exclusive rights until approximately 2025 or beyond, barring any legal challenges or lapses.

Scope of the Patent

The scope of a patent is defined by its claims, which specify the legal boundaries of protection. Analyzing these claims reveals the extent to which the patent prevents third-party activities.

Types of Claims

  • Product Claims: Likely cover a specific chemical entity or compound, including the pharmaceutical composition containing the active ingredient.
  • Method Claims: Could encompass methods of manufacturing, administering, or using the drug for particular indications.
  • Formulation Claims: May specify novel formulations or delivery systems designed for enhanced bioavailability or patient compliance.

Implication of Scope:
A broad claim scope could block competitors from producing similar compounds or formulations, whereas narrow claims limit enforceability. The scope determines the patent’s ability to prevent third-party infringement effectively and influences licensing potential.

Claim Language Analysis

Without access to the full patent text, typical claim structures in pharmaceutical patents are as follows:

  • Markush Claims: Covering a broad class of compounds with variable substituents, offering extensive protection.
  • Swiss-Style Claims: Focused on the compound’s structure minus specific features, or specific derivatives of the core molecule.
  • Use Claims: Covering specific therapeutic applications (e.g., treatment of a disease).

The actual scope hinges on whether claims are narrow (specific compounds or uses) or broad (entire classes of compounds or methods).

Claims Breakdown and Critical Elements

  • Novelty and Inventive Step:
    The claims must describe a novel compound or method not obvious over existing prior art. Patent examiners scrutinize whether the claimed compound’s structure or use is sufficiently inventive.

  • Key Chemical Features:
    The claims likely specify unique chemical moieties, stereochemistry, or substitution patterns that distinguish the invention.

  • Therapeutic Use:
    Use claims may specify use in treating a particular disease — a common strategy to extend patent life and market exclusivity.

Claim Validation and Limitations

The enforceability of the claims depends on their clarity, support in the specification, and the novelty over prior art. Any overly broad claims may be susceptible to invalidation unless backed by compelling inventive steps.

Patent Landscape Analysis

Understanding PE20050696's position within the broader patent ecosystem involves examining related patents, prior art, and potential patent families.

Related Patent Families and Patent Landscape

  • Prior Art:
    Pre-existing patents or publications may pertain to similar chemical entities, therapeutics, or formulation strategies. Notably, older patents or scientific literature prior to 2005 could challenge novelty.

  • Patent Families:
    PE20050696 may be part of a patent family with counterparts filed in key jurisdictions such as the US, Europe, or China. If international filings exist, they expand the scope of protection and influence in global markets.

  • Patent Citations:
    Backward citations highlight prior art, while forward citations indicate influence and validity. A high number of citations suggests a significant invention with broad impact.

Legal Challenges and Patent Life Cycle

  • Oppositions or Litigation:
    In Peru, patent validity may be challenged via administrative or judicial processes. The presence of such challenges could weaken exclusivity.

  • Expiration or Lapse:
    Given the typical patent life, PE20050696 is likely approaching expiry or may have already lapsed if maintenance fees were not paid or if legal challenges occurred.

Competitive Landscape and Innovation Trends

  • Generic Competition:
    Post-expiry, generic manufacturers can introduce biosimilar or generic versions, impacting market share.

  • Patent Cliff and Follow-up Patents:
    Follow-on patents or improvements could extend patent life or block competitors from entering specific niches.

  • Emerging Patents:
    Newer patents may encompass second-generation molecules, combination therapies, or improved formulations, shaping the competitive environment.

Implication for Stakeholders

  • Innovators and R&D Firms:
    Should evaluate whether PE20050696 protects core innovations or is narrow, guiding licensing or design-around strategies.

  • Generic Manufacturers:
    Can exploit patent expiry timelines or challenge patent validity based on prior art, particularly if claims are narrow.

  • Legal and Patent Counsel:
    Need to analyze claim scope meticulously to advise on potential infringement risks and validate patent strength.

Summary of Strengths and Vulnerabilities

Strengths Vulnerabilities
Likely claims cover a specific, potentially patentable compound/method Possible narrow claim scope reducing enforceability
If part of a patent family with international filings, global protection is bolstered Expiry approaching, or patent maintenance lapses, open market entry
If claims are well-structured and supported, enforceability remains high Potential prior art challenges or invalidation risks if claims are broad or unsupported

Key Takeaways

  • The scope of PE20050696 hinges on the specificity of its claims, which likely protect a novel chemical entity, formulation, or therapeutic method.
  • The patent’s strategic value depends on its breadth; narrow claims limit enforcement but reduce invalidation risks. Broad claims can provide strong market exclusivity but are more vulnerable to legal challenge.
  • The patent landscape reveals that related patents, prior art, and international filings are critical for assessing the patent’s strength and potential for global expansion.
  • As the patent nears expiration, stakeholders should prepare for market entry, licensing negotiations, or consider patent extensions through novel formulations or methods.
  • Vigilance for legal challenges and patent lapses remains essential to protect investment and market position.

FAQs

1. What is the typical lifespan of a pharmaceutical patent in Peru?
Pharmaceutical patents in Peru generally have a 20-year term from the filing date, subject to the payment of maintenance fees.

2. How can I determine the scope of claims in PE20050696?
Access the full patent document from the Peruvian patent office or authorized patent databases to examine the claims section, which precisely defines the patent’s legal protections.

3. Are there international equivalents or family patents related to PE20050696?
Investigate patent family databases such as WIPO or Espacenet to identify corresponding filings in other jurisdictions, indicating broader protection strategies.

4. What challenges could be faced in enforcing patent PE20050696?
Challenges include prior art invalidation, ambiguous claim language, or legal disputes that question the patent’s novelty or inventive step.

5. How does patent expiration affect market exclusivity?
Once a patent expires, generic manufacturers can produce equivalent products, increasing competition and potentially decreasing market share for the patentholder.

References

[1] Peruvian Patent Office (INDECOPI). Patent PE20050696 documentation.
[2] World Intellectual Property Organization (WIPO). Patent family and international filings analysis.
[3] Patent Law of Peru – Official Regulations and guidelines for patent validity and term.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.